Abstract
Dyspnea is a common and disabling symptom experienced by a majority of patients with cancer, especially as disease advances and they approach the end of life. Strategies aimed at reversing anatomical and physiological causes may relieve dyspnea and represent a first target of intervention. When underlying causes cannot be modified, global therapies focused on symptom relief should be enlisted; these also can be employed in conjunction with disease-targeted approaches. This chapter reviews both pharmacological and nonpharmacological treatments to be used in dyspnea in patients with cancer.
| Original language | English |
|---|---|
| Title of host publication | Evidence-Based Practice of Palliative Medicine, Second Edition |
| Editors | Nathan E. Goldstein, Christopher D. Woodrell, R. Sean Morrison |
| Place of Publication | Philadelphia, PA |
| Publisher | Elsevier |
| Chapter | 15 |
| Pages | 121-130 |
| Number of pages | 10 |
| Edition | Second edition |
| ISBN (Electronic) | 9780323847025 |
| ISBN (Print) | 9780323847032 |
| DOIs | |
| Publication status | Published - 2023 |
| Externally published | Yes |
Keywords
- air anxiety
- breathlessness
- dyspnea
- hospice
- morphine
- oxygen
- shortness of breath